Published in Curr Gene Ther on April 01, 2013
Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells. Hepatology (2014) 1.09
Tonsil-derived mesenchymal stem cells ameliorate CCl4-induced liver fibrosis in mice via autophagy activation. Sci Rep (2015) 0.99
Development and characterization of human-induced pluripotent stem cell-derived cholangiocytes. Lab Invest (2015) 0.86
Messenger RNA- versus retrovirus-based induced pluripotent stem cell reprogramming strategies: analysis of genomic integrity. Stem Cells Transl Med (2014) 0.84
Potential and Challenges of Induced Pluripotent Stem Cells in Liver Diseases Treatment. J Clin Med (2014) 0.76
The Use of Induced Pluripotent Stem Cells for the Study and Treatment of Liver Diseases. Curr Protoc Toxicol (2016) 0.76
A Convenient and Efficient Method to Enrich and Maintain Highly Proliferative Human Fetal Liver Stem Cells. Rejuvenation Res (2015) 0.75
Cell sources for in vitro human liver cell culture models. Exp Biol Med (Maywood) (2016) 0.75
Elongation of Axon Extension for Human iPSC-Derived Retinal Ganglion Cells by a Nano-Imprinted Scaffold. Int J Mol Sci (2017) 0.75
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Reprogramming of human somatic cells to pluripotency with defined factors. Nature (2007) 30.84
Genome editing with engineered zinc finger nucleases. Nat Rev Genet (2010) 18.88
Disease-specific induced pluripotent stem cells. Cell (2008) 16.95
In vivo reprogramming of adult pancreatic exocrine cells to beta-cells. Nature (2008) 16.21
Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science (2008) 14.26
Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature (2011) 13.94
Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell (2009) 13.02
Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science (2007) 12.41
Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature (2008) 12.21
Genetic engineering of human pluripotent cells using TALE nucleases. Nat Biotechnol (2011) 11.76
Adenovirus-associated virus vector-mediated gene transfer in hemophilia B. N Engl J Med (2011) 11.01
Somatic coding mutations in human induced pluripotent stem cells. Nature (2011) 9.50
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. J Clin Invest (2008) 9.42
Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet (2012) 7.70
Stepwise reprogramming of B cells into macrophages. Cell (2004) 7.68
Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci U S A (2010) 7.31
Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology (2010) 6.40
Direct conversion of mouse fibroblasts to hepatocyte-like cells by defined factors. Nature (2011) 5.84
The mechanism of Z alpha 1-antitrypsin accumulation in the liver. Nature (1992) 5.71
Induction of functional hepatocyte-like cells from mouse fibroblasts by defined factors. Nature (2011) 5.28
Human embryonic stem cells express an immunogenic nonhuman sialic acid. Nat Med (2005) 5.24
Robust expansion of human hepatocytes in Fah-/-/Rag2-/-/Il2rg-/- mice. Nat Biotechnol (2007) 5.04
Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature (2011) 4.92
Microscale culture of human liver cells for drug development. Nat Biotechnol (2007) 4.85
In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature (2011) 4.81
Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol (2011) 4.77
An extracellular matrix microarray for probing cellular differentiation. Nat Methods (2005) 4.35
Human hepatic stem cells from fetal and postnatal donors. J Exp Med (2007) 4.15
Differentiation and transplantation of human embryonic stem cell-derived hepatocytes. Gastroenterology (2008) 3.99
Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest (2010) 3.91
Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology (2005) 3.72
Organogenesis and development of the liver. Dev Cell (2010) 3.71
Tgf-beta superfamily signaling in embryonic development and homeostasis. Dev Cell (2009) 3.51
Generation of pluripotent stem cells from patients with type 1 diabetes. Proc Natl Acad Sci U S A (2009) 3.43
The role of hepatocytes and oval cells in liver regeneration and repopulation. Mech Dev (2003) 3.32
Targeted gene correction of laminopathy-associated LMNA mutations in patient-specific iPSCs. Cell Stem Cell (2011) 3.32
Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology (2007) 3.29
Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology (2010) 3.16
Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts. Cell Stem Cell (2008) 3.15
Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature (2012) 3.09
Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell (2010) 3.08
Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed. Stem Cells (2007) 3.04
Human hepatocyte transplantation: worldwide results. Transplantation (2006) 3.02
Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling. Proc Natl Acad Sci U S A (2008) 2.99
Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci Transl Med (2012) 2.80
Liver development update: new embryo models, cell lineage control, and morphogenesis. Curr Opin Genet Dev (2004) 2.71
Direct lineage conversions: unnatural but useful? Nat Biotechnol (2011) 2.69
A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med (1995) 2.65
Induced pluripotent stem cells--opportunities for disease modelling and drug discovery. Nat Rev Drug Discov (2011) 2.58
Erosion of dosage compensation impacts human iPSC disease modeling. Cell Stem Cell (2012) 2.42
Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy. Proc Natl Acad Sci U S A (2011) 2.41
Isolation of multipotent progenitor cells from human fetal liver capable of differentiating into liver and mesenchymal lineages. Proc Natl Acad Sci U S A (2006) 2.32
Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology (2008) 2.31
Pluripotency factors regulate definitive endoderm specification through eomesodermin. Genes Dev (2011) 2.22
Modeling hepatitis C virus infection using human induced pluripotent stem cells. Proc Natl Acad Sci U S A (2012) 2.20
A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. J Clin Invest (2010) 2.06
Human hepatic stem cell and maturational liver lineage biology. Hepatology (2011) 1.99
Mitochondrial Parkin recruitment is impaired in neurons derived from mutant PINK1 induced pluripotent stem cells. J Neurosci (2011) 1.98
Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells. Stem Cells (2009) 1.96
Signaling network crosstalk in human pluripotent cells: a Smad2/3-regulated switch that controls the balance between self-renewal and differentiation. Cell Stem Cell (2012) 1.94
Progenitor cells in diseased human liver. Semin Liver Dis (2003) 1.93
Clonal identification and characterization of self-renewing pluripotent stem cells in the developing liver. J Cell Biol (2002) 1.88
Zinc finger protein-dependent and -independent contributions to the in vivo off-target activity of zinc finger nucleases. Nucleic Acids Res (2010) 1.81
Donor-dependent variations in hepatic differentiation from human-induced pluripotent stem cells. Proc Natl Acad Sci U S A (2012) 1.78
Epigenetic characterization of the FMR1 gene and aberrant neurodevelopment in human induced pluripotent stem cell models of fragile X syndrome. PLoS One (2011) 1.75
Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells. Proc Natl Acad Sci U S A (2012) 1.69
Complete reconstitution of mouse liver with xenogeneic hepatocytes. Proc Natl Acad Sci U S A (1995) 1.65
Unbiased screening of polymer libraries to define novel substrates for functional hepatocytes with inducible drug metabolism. Stem Cell Res (2010) 1.62
Elevated coding mutation rate during the reprogramming of human somatic cells into induced pluripotent stem cells. Stem Cells (2012) 1.62
Factors affecting hepatocyte isolation, engraftment, and replication in an in vivo model. Liver Transpl (2010) 1.57
Biomedicine. Lowering LDL--not only how low, but how long? Science (2006) 1.54
Differentiation and enrichment of hepatocyte-like cells from human embryonic stem cells in vitro and in vivo. Stem Cells (2007) 1.54
Differentiation and isolation of hepatic-like cells from human embryonic stem cells. Differentiation (2004) 1.53
Complete Plasmodium falciparum liver-stage development in liver-chimeric mice. J Clin Invest (2012) 1.52
Human hepatocyte transplantation: current experience and future challenges. Nat Rev Gastroenterol Hepatol (2010) 1.52
Activin/Nodal signaling controls divergent transcriptional networks in human embryonic stem cells and in endoderm progenitors. Stem Cells (2011) 1.51
Diseases in a dish: modeling human genetic disorders using induced pluripotent cells. Nat Med (2011) 1.50
The therapeutic potential of human umbilical mesenchymal stem cells from Wharton's jelly in the treatment of rat liver fibrosis. Liver Transpl (2009) 1.50
Isolation of human progenitor liver epithelial cells with extensive replication capacity and differentiation into mature hepatocytes. J Cell Sci (2002) 1.49
Liver regeneration and recanalization time course following reversible portal vein embolization. J Hepatol (2008) 1.49
Kupffer cells participate in early clearance of syngeneic hepatocytes transplanted in the rat liver. Gastroenterology (2002) 1.33
Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant (2012) 1.31
Current status of hepatocyte transplantation. Transplantation (2012) 1.28
Productive infection of primary human endothelial cells by pig endogenous retrovirus (PERV). Xenotransplantation (2000) 1.25
Paracrine signals from mesenchymal cell populations govern the expansion and differentiation of human hepatic stem cells to adult liver fates. Hepatology (2010) 1.22
Differentiation of mouse embryonic stem cells to hepatocyte-like cells by co-culture with human liver nonparenchymal cell lines. Nat Protoc (2007) 1.22
Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin. Hum Mol Genet (2011) 1.20
Persistence of functional hepatocyte-like cells in immune-compromised mice. Liver Int (2010) 1.18
Defined conditions for development of functional hepatic cells from human embryonic stem cells. Stem Cells Dev (2005) 1.16
Two years after molecular diagnosis of familial hypercholesterolemia: majority on cholesterol-lowering treatment but a minority reaches treatment goal. PLoS One (2010) 1.14
Human pluripotent stem cell-derived hepatocytes support complete replication of hepatitis C virus. J Hepatol (2012) 1.11
CpG island methylator phenotype association with upregulated telomerase activity in hepatocellular carcinoma. Int J Cancer (2008) 1.11
Human disease modeling with induced pluripotent stem cells. Curr Opin Genet Dev (2012) 1.08
Mechanisms of emphysema in alpha1-antitrypsin deficiency: molecular and cellular insights. Eur Respir J (2009) 1.07
Optimization of the cryopreservation and thawing protocol for human hepatocytes for use in cell transplantation. Liver Transpl (2010) 1.07
Hepatocyte-like cells derived from human embryonic stem cells specifically via definitive endoderm and a progenitor stage. J Biotechnol (2009) 1.05
Repopulation of athymic mouse liver by cryopreserved early human fetal hepatoblasts. Hum Gene Ther (2004) 1.03
Concise review: alchemy of biology: generating desired cell types from abundant and accessible cells. Stem Cells (2011) 1.03
Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature (2007) 11.72
Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells. Nature (2011) 4.92
Senescence impairs successful reprogramming to pluripotent stem cells. Genes Dev (2009) 4.69
Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest (2010) 3.91
The cell-cycle state of stem cells determines cell fate propensity. Cell (2013) 3.50
Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology (2010) 3.16
Inhibition of Activin/Nodal signaling promotes specification of human embryonic stem cells into neuroectoderm. Dev Biol (2007) 2.46
Pluripotency factors regulate definitive endoderm specification through eomesodermin. Genes Dev (2011) 2.22
Early cell fate decisions of human embryonic stem cells and mouse epiblast stem cells are controlled by the same signalling pathways. PLoS One (2009) 2.18
FOXO1 regulates L-Selectin and a network of human T cell homing molecules downstream of phosphatidylinositol 3-kinase. J Immunol (2008) 1.97
Signaling pathways controlling pluripotency and early cell fate decisions of human induced pluripotent stem cells. Stem Cells (2009) 1.96
A randomized trial of colpopexy and urinary reduction efforts (CARE): design and methods. Control Clin Trials (2003) 1.93
Ex vivo expansion of human hematopoietic stem cells by direct delivery of the HOXB4 homeoprotein. Nat Med (2003) 1.81
Activin/Nodal signaling controls divergent transcriptional networks in human embryonic stem cells and in endoderm progenitors. Stem Cells (2011) 1.51
Liver regeneration and recanalization time course following reversible portal vein embolization. J Hepatol (2008) 1.49
Caspase-8 prevents sustained activation of NF-kappaB in monocytes undergoing macrophagic differentiation. Blood (2006) 1.48
Production of hepatocyte-like cells from human pluripotent stem cells. Nat Protoc (2013) 1.44
Increased engraftment of hepatic progenitors after activation of the hepatocyte growth factor signaling pathway by protein transduction. Exp Biol Med (Maywood) (2009) 1.40
Transplantation of expanded fetal intestinal progenitors contributes to colon regeneration after injury. Cell Stem Cell (2013) 1.39
Sexual function 6 months after first delivery. Obstet Gynecol (2008) 1.39
Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London. Cell Transplant (2012) 1.31
Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein. Proc Natl Acad Sci U S A (2004) 1.28
Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species. Cell Microbiol (2006) 1.25
Outcomes following vaginal prolapse repair and mid urethral sling (OPUS) trial--design and methods. Clin Trials (2009) 1.24
SIP1 mediates cell-fate decisions between neuroectoderm and mesendoderm in human pluripotent stem cells. Cell Stem Cell (2010) 1.21
HOXB4 overexpression promotes hematopoietic development by human embryonic stem cells. Stem Cells (2006) 1.14
Emerging use of stem cells in regenerative medicine. Biochem J (2010) 1.14
Operations and pelvic muscle training in the management of apical support loss (OPTIMAL) trial: design and methods. Contemp Clin Trials (2008) 1.14
Pleiotrophin enhances clonal growth and long-term expansion of human embryonic stem cells. Stem Cells (2007) 1.12
Generation of functional cholangiocyte-like cells from human pluripotent stem cells and HepaRG cells. Hepatology (2014) 1.09
Expression of Pitx2 in stromal cells is required for normal hematopoiesis. Blood (2005) 1.07
Generation of multipotent foregut stem cells from human pluripotent stem cells. Stem Cell Reports (2013) 1.05
Repopulation of athymic mouse liver by cryopreserved early human fetal hepatoblasts. Hum Gene Ther (2004) 1.03
Real-time PCR mapping of DNaseI-hypersensitive sites using a novel ligation-mediated amplification technique. Nucleic Acids Res (2007) 1.03
Establishment of immortalized human hepatic stellate scavenger cells to develop bioartificial livers. Transplantation (2003) 1.01
Characterization of DNA-binding-dependent and -independent functions of SCL/TAL1 during human erythropoiesis. Blood (2004) 1.00
Establishment of a highly differentiated immortalized human cholangiocyte cell line with SV40T and hTERT. Transplantation (2004) 1.00
Embryonic stem cell therapy for diabetes mellitus. Semin Cell Dev Biol (2007) 0.99
E-cadherin/p120-catenin and tetraspanin Co-029 cooperate for cell motility control in human colon carcinoma. Cancer Res (2010) 0.97
Genomic targets of Brachyury (T) in differentiating mouse embryonic stem cells. PLoS One (2012) 0.96
A practical and efficient cellular substrate for the generation of induced pluripotent stem cells from adults: blood-derived endothelial progenitor cells. Stem Cells Transl Med (2012) 0.95
No differences between 20, 30, or 40 mL ropivacaine 0.5% in continuous lateral popliteal sciatic-nerve block. Reg Anesth Pain Med (2006) 0.95
Maximal lentivirus-mediated gene transfer and sustained transgene expression in human hematopoietic primitive cells and their progeny. Mol Ther (2002) 0.95
Biphasic induction of Pdx1 in mouse and human embryonic stem cells can mimic development of pancreatic beta-cells. Stem Cells (2009) 0.93
Nuclear transfer-derived epiblast stem cells are transcriptionally and epigenetically distinguishable from their fertilized-derived counterparts. Stem Cells (2010) 0.93
Rescue of early-stage myelodysplastic syndrome-deriving erythroid precursors by the ectopic expression of a dominant-negative form of FADD. Blood (2005) 0.92
Efficient hepatocyte engraftment and long-term transgene expression after reversible portal embolization in nonhuman primates. Hepatology (2009) 0.92
Long-term controlled immortalization of a primate hepatic progenitor cell line after Simian virus 40 T-Antigen gene transfer. Oncogene (2005) 0.90
Ex vivo liver-directed gene therapy for the treatment of metabolic diseases: advances in hepatocyte transplantation and retroviral vectors. Curr Gene Ther (2009) 0.90
Cerebrospinal fluid density influences extent of plain bupivacaine spinal anesthesia. Anesthesiology (2002) 0.89
The serpinopathies studying serpin polymerization in vivo. Methods Enzymol (2011) 0.89
Transduced CD34+ cells from adrenoleukodystrophy patients with HIV-derived vector mediate long-term engraftment of NOD/SCID mice. Mol Ther (2003) 0.89
Immortalization of a primate bipotent epithelial liver stem cell. Proc Natl Acad Sci U S A (2002) 0.88
Teaching and practicing of pelvic floor muscle exercises in primiparous women during pregnancy and the postpartum period. Am J Obstet Gynecol (2007) 0.88
Induced pluripotent stem cells--alchemist's tale or clinical reality? Expert Rev Mol Med (2010) 0.87
Efficient hepatocyte engraftment in a nonhuman primate model after partial portal vein embolization. Transplantation (2006) 0.87
Status of genomic imprinting in epigenetically distinct pluripotent stem cells. Stem Cells (2012) 0.87
First description of the surgical anatomy of the cynomolgus monkey liver. Am J Primatol (2009) 0.87
SCL/TAL1 expression level regulates human hematopoietic stem cell self-renewal and engraftment. Blood (2005) 0.85
Improved gene transfer selectivity to hepatocarcinoma cells by retrovirus vector displaying single-chain variable fragment antibody against c-Met. Cancer Gene Ther (2003) 0.85
Clinical experience with survivin as a biomarker for urothelial bladder cancer. World J Urol (2010) 0.85
Glycoprotein Ibalpha promoter drives megakaryocytic lineage-restricted expression after hematopoietic stem cell transduction using a self-inactivating lentiviral vector. Stem Cells (2007) 0.85
Mouse pluripotent stem cells at a glance. J Cell Sci (2011) 0.84
Multiple roles of Activin/Nodal, bone morphogenetic protein, fibroblast growth factor and Wnt/β-catenin signalling in the anterior neural patterning of adherent human embryonic stem cell cultures. Open Biol (2013) 0.83
Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum. Biomark Insights (2010) 0.83
Isobaric versus hypobaric spinal bupivacaine for total hip arthroplasty in the lateral position. Anesth Analg (2003) 0.82
NACA is a positive regulator of human erythroid-cell differentiation. J Cell Sci (2005) 0.82
Efficient ex vivo gene transfer into non-human primate hepatocytes using HIV-1 derived lentiviral vectors. J Hepatol (2006) 0.81
Gene transfer of constitutively active caspase-3 induces apoptosis in a human hepatoma cell line. J Gene Med (2005) 0.81
Integration-deficient lentivectors: an effective strategy to purify and differentiate human embryonic stem cell-derived hepatic progenitors. BMC Biol (2013) 0.80
Pancreatic transcription factors containing protein transduction domains drive mouse embryonic stem cells towards endocrine pancreas. PLoS One (2012) 0.79
Survival and differentiation of adenovirus-generated induced pluripotent stem cells transplanted into the rat striatum. Cell Transplant (2013) 0.79
In vitro generated Rh(null) red cells recapitulate the in vivo deficiency: a model for rare blood group phenotypes and erythroid membrane disorders. Am J Hematol (2013) 0.78
Navigating the pathway from embryonic stem cells to beta cells. Semin Cell Dev Biol (2004) 0.78
Stem cell factor-displaying simian immunodeficiency viral vectors together with a low conditioning regimen allow for long-term engraftment of gene-marked autologous hematopoietic stem cells in macaques. Hum Gene Ther (2012) 0.78
Activin/nodal signaling and pluripotency. Vitam Horm (2011) 0.78
In vivo imaging of transplanted hepatocytes with a 1.5-T clinical MRI system--initial experience in mice. Eur Radiol (2007) 0.78
The role of HGF on invasive properties and repopulation potential of human fetal hepatic progenitor cells. Exp Cell Res (2009) 0.78
[Robust differentiation of fetal hepatocytes from human embryonic stem cells and iPS]. Med Sci (Paris) (2010) 0.78
Portal branch ligation induces efficient retrovirus-mediated gene delivery in rat liver. J Gene Med (2004) 0.77
Targeting of c-Met and urokinase expressing human glioma cell lines by retrovirus vector displaying single-chain variable fragment antibody. Cancer Biol Ther (2005) 0.77
Thrombopoietin-induced Dami cells as a model for alpha-granule biogenesis. Platelets (2004) 0.77
In utero allotransplantation of fetal hepatocytes in primates. Fetal Diagn Ther (2003) 0.77
Intrathecal sufentanil is more potent than intravenous for postoperative analgesia after total-hip replacement. Reg Anesth Pain Med (2005) 0.76
Volumetric Portal Embolization: A New Concept to Improve Liver Regeneration and Hepatocyte Engraftment. Transplantation (2016) 0.76
Human stem cells for craniomaxillofacial reconstruction. Stem Cells Dev (2014) 0.75
Fucci2a mouse upgrades live cell cycle imaging. Cell Cycle (2015) 0.75
Improvement of hepatocyte transplantation efficiency in the mdr2-/- mouse model by glyceryl trinitrate. Transplantation (2015) 0.75
A factor(s) secreted from MIN-6 beta-cells stimulates differentiation of definitive endoderm enriched embryonic stem cells towards a pancreatic lineage. Mol Cell Endocrinol (2010) 0.75
Retroviral display of urokinase-binding domain fused to amphotropic envelope protein. Biochem Biophys Res Commun (2005) 0.75
[Human embryonic stem cells to rescue fulminant hepatic failure]. Med Sci (Paris) (2006) 0.75
Influence of dissolved inorganic carbon and calcium on gas formation and accumulation in iron permeable reactive barriers. J Contam Hydrol (2012) 0.75